Based on our pilot analysis, PIT values and their anemia-corrected variants appeared to be higher in the CgA+ group (Figure A2) even though aggregation inhibition therapy was more common in the CgA+ group (CgA−: 2 of the 15 patients (13%), CgA+: 5 of the 8 patients (62.5%), p = 0.0257). The gene discussed is CGA; the disease is anemia (phenotype).